Phase 2a study of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of wild-type TP53 in patients with peripheral t-cell lymphoma Meeting Abstract
| Authors: | Payton, M.; Pinchasik, D.; Mehta, A.; Goel, S.; Zain, J. M.; Sokol, L.; Jacobsen, E.; Patel, M. R.; Horwitz, S. M.; Meric-Bernstam, F.; Shustov, A.; Weinstock, D.; Aivado, M.; Annis, D. A. |
| Abstract Title: | Phase 2a study of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of wild-type TP53 in patients with peripheral t-cell lymphoma |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx373.045 |
| Language: | English |
| ACCESSION: | WOS:000411324002227 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx373.045 |
| Notes: | Meeting Abstract: 1039TiP -- Appears on page 370 of the abstract book -- Source: Wos |
